SOLICITATION NOTICE
66 -- COMBINED SYNOPSIS/SOLICITATION
- Notice Date
- 9/14/2006
- Notice Type
- Solicitation Notice
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- Department of the Air Force, Air Force Materiel Command, HQ HSG - Human Systems Group, HQ HSG/YASK 7980 Lindbergh Landing, Brooks City-Base, TX, 78235-5119, UNITED STATES
- ZIP Code
- 00000
- Solicitation Number
- F1JEAB6248A100
- Response Due
- 9/19/2006
- Archive Date
- 10/4/2006
- Description
- This is a Combined Synopsis/Solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. In accordance with FAR 6.301, 10 U.S.C 2304(c)(1), Only one responsible source and no other supplies or services will satisfy agency requirements. The Air Force Institute for Operational Health, Applied Technology Center (AFIOH/ATC) will procure BioVeris testing kits for the M-SERIES? M1M System?s in direct support of FY06 Modernization Division, Office of the Surgeon General funded project. The procurement of lyophilized (dried down) testing kits and reagents for the following pathogens/toxins: Y.pestis, F.tularensis, B.anthracis, Brucella spp., Botulinum Neurotoxin A, and Staphylococcal Enterotoxin A. The testing kits will be used specifically on the M-SERIES? M1M analyzer, which has been chosen by the Air Force to be one of the analyzers listed on the Homeland Defense Laboratory Response Team (HLD LRT) allowance standard (886B). These field-ready testing kits will be optimized in various food and water matrices. The reagents support the testing kits. BioVeris Corporation develops and markets biological detection systems based on its proprietary electrochemiluminescent (ECL) technology (BioVeris BV? detection technology), which provides a unique combination of sensitivity, reliability, speed, and flexibility. BioVeris incorporates its BV detection technology into its instrument systems, tests, and reagents (which are the biological and chemical components used to perform such tests). These instrument systems, tests, and reagents are marketed directly by BioVeris and for a wide variety of applications, including Biodefense tests, pharmaceutical research and development, life science research, and industrial testing for food safety and quality control. This solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular http://farsite.hill.af.mil. The following provisions/clauses are applicable: 52.212-1, Instructions to Offerors?Commercial; 52.212-2, Evaluation?Commercial Items -- Award will be based upon providing the products and price; 52.212-3, Offeror Representations and Certifications?Commercial Items; 52.212-4, Contract Terms and Conditions?Commercial Items; 52.212-5, Contract Terms and Conditions Required To Implement Statutes or Executive Orders?Commercial Items; and 252.212-7001 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Applicable to Defense Acquisitions of Commercial Items. QUOTE IS DUE 19 SEP 06 NLT 2:00 PM CENTRAL STANDARD TIME.
- Place of Performance
- Address: AFIOH/ATC, 2350 GILLINGHAM DR, BLDG 140, BROOKS CITY-BASE TX
- Zip Code: 78235
- Country: UNITED STATES
- Zip Code: 78235
- Record
- SN01143660-W 20060916/060914221038 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |